Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1999
03/30/1999US5888991 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
03/30/1999US5888988 Wound healing agent
03/30/1999US5888978 Method for reducing the severity of gastro-intestinal damage
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888967 Administering urokinases, tissue plasminogen activator andstreptokinase
03/30/1999US5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999CA2249049A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same
03/30/1999CA2170608C 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/30/1999CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use
03/30/1999CA2047216C 9-substituted-8-unsubstituted-9-deazaguanines
03/25/1999WO1999014343A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014321A1 Novel therapeutic molecules
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014194A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999WO1999013912A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999WO1999013911A1 Nootropic agent
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013909A1 Corneal neovascularization inhibitors
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013888A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999WO1999013878A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013872A1 Antimicrobials
03/25/1999WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates
03/25/1999WO1999013719A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999WO1999013717A1 A delivery of arginine to cause beneficial effects
03/25/1999WO1999003822A8 Bicyclic metabotropic glutamate receptor ligands
03/25/1999WO1999001427A3 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT
03/25/1999WO1998042296A3 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304309A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303908A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2303178A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302251A1 Antimicrobial agent
03/25/1999CA2302204A1 A combination of a monoamine oxidase inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2301782A1 Nootropic agent
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0903148A2 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
03/24/1999EP0903145A2 Pharmaceutical composition for skin disorders
03/24/1999EP0902835A1 Purification of pharmaceutical-grade plasmid dna
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0902782A1 Urea derivatives as inhibitors of impdh enzyme
03/24/1999EP0902684A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0716650B1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999EP0640085B1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
03/24/1999EP0560937B1 Pharmaceutical compositions
03/24/1999EP0534978B1 Interleukin-1 antagonist and uses thereof
03/24/1999EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
03/24/1999CN1211987A Camptothecin derivatives and use thereof as antimutor agents
03/24/1999CN1211985A Fused imidazole derivatives as multidrug resistance modulators
03/24/1999CN1211578A PEG-inerferon conjugates
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/24/1999CN1211447A Baiyesan-medicinal powder
03/24/1999CN1211419A Cell renewal rate compositions
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886036 Treating hiv infections
03/23/1999US5886025 Methoxy and ethoxy substituted 3-aroyl-2-arylbenzo(b)thiophenes and benzo(b)thiophene analogues
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5886004 Tetrahydrobetacarboline compounds
03/23/1999US5886003 Administering 5-ht2 antagonists
03/23/1999US5885988 Benzo g!quinoline derivatives
03/23/1999US5885986 Cleaving, n-alkylating and reducing the intermediate formed by reacting an oxazolyl and thiazolylimidazobenzo and thienodiazepine derivatives with amine compounds; used as anxiolytic and anticonvulsant or sedative-hypnotic agents
03/23/1999US5885982 Use of transglutaminase inhibitor for the treatment of scar tissue
03/23/1999US5885964 Administering to the patient suffering from osteoporosis an effective amount of an agent comprising kininogen or kininogen peptide to prevent bone resorption
03/23/1999US5885805 gbpA
03/23/1999US5885619 Large area submucosal tissue graft constructs and method for making the same
03/23/1999US5885595 Treating skin disorder with acne, follicular and lesional papules, actinic keratoses, oily skin and rosacea
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them
03/23/1999CA2092794C Naphthylalkylamines, process for their preparation and pharmaceutical compositions that contain them
03/23/1999CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists
03/23/1999CA1340455C Human preproinsulin-like growth factor i
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/18/1999WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
1 ... 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 ... 1564